Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed Daha

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Immunology|March 27, 2017
Preface to the special issueMohamed Daha, Claudia Kemper
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenotypic and functional maturation of human dendritic cellsRolf Spirig, Cees van Kooten, Carolina Obregon, et al.
Molecular Genetics and Metabolism|August 4, 2019
Pegvaliase: Immunological profile and recommendations for the clinical management of hypersensitivity reactions in patients with phenylketonuria treated with this enzyme substitution therapyOliver Hausmann, Mohamed Daha, Nicola Longo, et al.
Experimental Hematology & Oncology|December 20, 2021
Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathyEleni Gavriilaki, Vincent T Ho, Wilhelm Schwaeble, et al.
Journal of Immunological Methods|December 9, 2003
The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assayRichard Tacey, Anthony Greway, Janice Smiell, et al.
Digestive Diseases and Sciences|June 26, 2003
High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitisLászló Bene, George Füst, Béla Fekete, et al.
Kidney International|March 26, 2010
Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboonsXavier Tillou, Nicolas Poirier, Stéphanie Le Bas-Bernardet, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Immunology|March 27, 2017
Preface to the special issueMohamed Daha, Claudia Kemper
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenotypic and functional maturation of human dendritic cellsRolf Spirig, Cees van Kooten, Carolina Obregon, et al.
Molecular Genetics and Metabolism|August 4, 2019
Pegvaliase: Immunological profile and recommendations for the clinical management of hypersensitivity reactions in patients with phenylketonuria treated with this enzyme substitution therapyOliver Hausmann, Mohamed Daha, Nicola Longo, et al.
Experimental Hematology & Oncology|December 20, 2021
Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathyEleni Gavriilaki, Vincent T Ho, Wilhelm Schwaeble, et al.
Journal of Immunological Methods|December 9, 2003
The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assayRichard Tacey, Anthony Greway, Janice Smiell, et al.
Digestive Diseases and Sciences|June 26, 2003
High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitisLászló Bene, George Füst, Béla Fekete, et al.
Kidney International|March 26, 2010
Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboonsXavier Tillou, Nicolas Poirier, Stéphanie Le Bas-Bernardet, et al.
Pageof 1